Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moutschen

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. The drug of the month. Nevirapine. Viramune]D Nkoghe, P Léonard, M Moutschen, et al.
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. How I treat ... HIV infection. III. Non-nucleoside reverse transcriptase inhibitors]D Nkoghe, M Moutschen, P Léonard, et al.
Revue Medicale De Liege|September 9, 2022
[Phage therapy, an additional strategy against multidrug-resistant bacteria]M Boniver, P Wotquenne, M Moutschen, et al.
Revue Medicale De Liege|April 11, 2001
[Autoimmune thyroiditis]V Geenen, E Warzee, M Moutschen, et al.
Revue Medicale De Liege|December 10, 1999
[Varicella pneumonia]D Nkoghe, M Moutschen, J Demonty, et al.
Revue Medicale De Liege|October 31, 2002
[Management of HIV infected patients. Experience of the Liege University Hospital Center]D Nkoghe, P Léonard, S Nnegue, et al.
Acta Clinica Belgica|December 5, 2002
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practiceP Blaise, P Clevenbergh, D Vaira, et al.
Mutation Research|July 1, 1982
Genetic effects in the mouse of formaldehyde in combination with adenosine and hydrogen peroxideN Fontignie-Houbrechts, M Moutschen-Dahmen, N Degraeve, et al.
Revue Medicale De Liege|March 20, 2002
[Morphological and metabolic abnormalities related to antiretroviral therapy]X Debruyn, D Nkoghe, P Leonard, et al.
Revue Medicale De Liege|March 26, 2009
[A fixed dose anti-HIV combination for the poor? Triomune]M Villar Garcia, D Mukeba-Tshialala, D Vaira, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. The drug of the month. Nevirapine. Viramune]D Nkoghe, P Léonard, M Moutschen, et al.
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. How I treat ... HIV infection. III. Non-nucleoside reverse transcriptase inhibitors]D Nkoghe, M Moutschen, P Léonard, et al.
Revue Medicale De Liege|September 9, 2022
[Phage therapy, an additional strategy against multidrug-resistant bacteria]M Boniver, P Wotquenne, M Moutschen, et al.
Revue Medicale De Liege|April 11, 2001
[Autoimmune thyroiditis]V Geenen, E Warzee, M Moutschen, et al.
Revue Medicale De Liege|December 10, 1999
[Varicella pneumonia]D Nkoghe, M Moutschen, J Demonty, et al.
Revue Medicale De Liege|October 31, 2002
[Management of HIV infected patients. Experience of the Liege University Hospital Center]D Nkoghe, P Léonard, S Nnegue, et al.
Acta Clinica Belgica|December 5, 2002
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practiceP Blaise, P Clevenbergh, D Vaira, et al.
Mutation Research|July 1, 1982
Genetic effects in the mouse of formaldehyde in combination with adenosine and hydrogen peroxideN Fontignie-Houbrechts, M Moutschen-Dahmen, N Degraeve, et al.
Revue Medicale De Liege|March 20, 2002
[Morphological and metabolic abnormalities related to antiretroviral therapy]X Debruyn, D Nkoghe, P Leonard, et al.
Revue Medicale De Liege|March 26, 2009
[A fixed dose anti-HIV combination for the poor? Triomune]M Villar Garcia, D Mukeba-Tshialala, D Vaira, et al.
Pageof 11